title: [The clinical assessment of the results of predicting individual sensitivity to adjuvant chemotherapy in lung tumors].
abstract: The value of subrenal capsule assay for predicting individual chemoresistance of tumor was evaluated using samples from 32 lung carcinomas. Treatment with drugs which had proved effective in the test was followed by a recurrence-free period of 15.5 +/- 3.7 months, as compared to 8.0 +/- 1.0 months for patients receiving ineffective drugs.
authors.forename: N S
authors.initials: NS
authors.lastname: Sergeeva
authors.forename: O I
authors.initials: OI
authors.lastname: Skotnikova
authors.forename: V I
authors.initials: VI
authors.lastname: Chissov
authors.forename: V I
authors.initials: VI
authors.lastname: Borisov
authors.forename: A Kh
authors.initials: AKh
authors.lastname: Trakhtenberg
authors.forename: L A
authors.initials: LA
authors.lastname: Bil'danova
authors.forename: I I
authors.initials: II
authors.lastname: Pelevina
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000473:pathology; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018288:Carcinoma, Small Cell / Q000188:drug therapy* / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000473:pathology; D017024:Chemotherapy, Adjuvant; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D051379:Mice; D008808:Mice, Inbred CBA; D009367:Neoplasm Staging; D011379:Prognosis; D013370:Subrenal Capsule Assay
chemical_list: D000970:Antineoplastic Agents
vernacular_title: Klinicheskaia otsenka rezul'tatov prognozirovaniia individual'noĭ chuvstvitel'nosti k ad''iuvantnoĭ khimioterapii opukholeĭ legkogo.